A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01)
Patent
CA 2097589
The invention relates to a method for the targeting of a therapeutic agent to a specific population of cells, wherein a complex is formed between the therapeutic agent and a polysaccharide capable of interacting with a cell receptor. and wherein the resulting complex is internalized into the cell by receptor mediated endocytosis (RME). In one embodiment of the invention, a complex of a therapeutic agent containing iron and the polysaccharide arabinogalactan may be formed and used to deliver iron specifically to hepatocytes by RME.
L'invention concerne une méthode pour diriger un agent thérapeutique vers une population précise de cellules, consistant en la formation d'un complexe entre l'agent thérapeutique et un polyoside capable d'interagir avec un récepteur de la cellule. Le complexe résultant pénètre dans la cellule par endocytose assistée par le récepteur (RME). Dans un modèle de l'invention, un complexe peut se former entre un agent thérapeutique contenant du fer et le polyoside arabinogalactane et servir à acheminer du fer plus particulièrement aux cellules hépatiques par RME.
Groman Ernest V.
Josephson Lee
Jung Chu
Lewis Jerome M.
Amag Pharmaceuticals Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Targeting of therapeutic agents using polysaccharides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting of therapeutic agents using polysaccharides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting of therapeutic agents using polysaccharides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1693100